| Issue Date | Title | Involved Person(s) |
| 14-Feb-2022 | Opinion: Regulators are approving drugs without clear evidence that they work | Hengartner, Michael Pascal |
| 2022 | Suizidpräventive Effekte von Ketamin und Esketamin | Plöderl, Martin; Hengartner, Michael P.; Volkmann, Constantin |
| Dec-2021 | Evidence-biased antidepressant prescription : overmedicalisation, flawed research, and conflicts of interest | Hengartner, Michael P. |
| 8-Nov-2021 | Learning about the course of suicidal behavior but not about the effects of SSRIs | Plöderl, Martin; Hengartner, Michael Pascal |
| 2021 | Latrogenic effects of the FDA black box warning on antidepressants – signal or noise? | Plöderl, Martin; Hengartner, Michael P. |
| 2021 | Maintenance therapy with antidepressants : prophylactic effects or withdrawal reactions? | Plöderl, Martin; Hengartner, Michael P. |
| 2021 | Suicide risk with selective serotonin reuptake inhibitors and other new-generation serotonergic-noradrenergic antidepressants in adults : a meta-analysis of observational studies | Hengartner, Michael P.; Plöderl, Martin; Amendola, Simone; Kindler, Simone; Bschor, Tom, et al |
| Aug-2020 | Antidepressiva gegen Depressionen : aktuelle Kontroversen um Nutzen und Risiken | Hengartner, Michael Pascal |
| 2020 | Cannabis use during adolescence and the occurrence of depression, suicidality and anxiety disorder across adulthood : findings from a longitudinal cohort study over 30 years | Hengartner, Michael Pascal; Angst, Jules; Ajdacic-Gross, Vladeta; Rössler, Wulf |
| 2020 | The impact of patientsʼ and therapistsʼ views of the therapeutic alliance on treatment outcome in psychotherapy | Tschuschke, Volker; Koemeda-Lutz, Margit; von Wyl, Agnes; Crameri, Aureliano; Schulthess, Peter |
| 2020 | Commentary to “antidepressants and suicidality : a re-analysis of the re-analysis” | Plöderl, Martin; Hengartner, Michael Pascal; Bschor, Tom; Kaminski, Jakob André |
